Inspection Findings:
Based on observation, interview and record review, the facility failed to identify, monitor, and evaluate individualized expressions of depression for 2 of 5 residents (R10 and R6) reviewed for unnecessary medication use. These failures increased the potential of not providing the correct data to the prescriber and represented an incomplete evaluation to determine the ongoing use and need for psychotropic antidepressant medications and increased the residents' risk for receiving unnecessary medications with its associated side effects and complications.
Findings include:
Facility policy Psychotropic Medication Use, dated July 2022, documented anti-depressants were considered psychotropic medications. "Psychotropic medication management includes ....d. adequate monitoring for efficacy and adverse consequences ....8. Consideration of the use of any psychotropic medication is based on comprehensive review of the resident. This includes evaluation of the resident's signs and symptoms in order to identify underlying causes."
Resident 10
Review of Resident 10's (R10) record indicated the facility admitted the resident in November 2023 with diagnoses including depression, diabetes, and dementia. R10's Minimum Data Set (MDS-assessment tool) dated 3/24/24 documented resident's brief interview for mental status was 13, indicating resident was cognitively intact.
Review of R10's current physician orders documented Citalopram Hydrobromide (Celexa, antidepressant) Oral Tablet 20 MG **DAW** ** (Dispense as written) Give 20 mg by mouth one time a day for Depression. Start date 12/13/23.
Review of R10's current Medication Administration Record, Treatment Administration Record, Progress Notes, Point of Care (POC) Response History of Behaviors since 12/28/23 to 4/24/26 showed resident did not exhibit any of the listed behaviors. The listed behaviors were physical behaviors directed at others (grabbing others, hitting others, kicking others, pushing others, physically aggressive towards others, scratching others), verbal behaviors directed at others (accusing of others, cursing at others, express frustration/anger at others, screaming at others, threatening others), socially inappropriate behaviors (disruptive sounds, disrobing in public, entering other resident's rooms/personal space, public sexual acts, repetitive motions rummaging, spitting, throwing/smearing food, throwing/smearing bodily waste), other behaviors not directed at others (agitated, anxious, restless, delusions, elopement/exit seeking, hallucinations, hitting, hoarding, insomnia, not sleeping, neglecting self care, pacing, panic, picking at self, refusing care, sad/tearful, scratching self, screaming not at other, self injury, wandering, withdrawing/isolating. The behaviors outlined in the Behavior Monitoring was not resident-centered, individualized or specific to the resident.
During an interview on 4/24/24 at 9:46 AM R10 was sitting in wheelchair in room. Resident stated that Celexa antidepressant did not sound familiar to her but stated that she did take an anti-depressant. When asked how someone would know she's depressed, R10 stated that sometimes she gets depressed and this occurs when she is worried about her family and she would tell others that she is worried and thinking about things or if she can't sleep because she is thinking about things. R10 stated that last night she woke up thinking it was time to get up but it was only midnight. It was quiet and she had too much time to think and worry and that's when she blows things out of proportion.
During an interview on 4/25/24 at 1:33 PM Certified Medication Aide (CMA)1 stated that she knew R10 well and she knows resident is depressed when she just stays in bed and doesn't want to go to activities
During an interview 4/24/24 at 2:41 PM Director of Nursing (DON) stated that when R10 first came to the facility, resident was tearful. When asked how R10 expressed depressive behavior, DON stated that it was tearfulness and social isolation and if these behaviors are seen, then medications are adjusted. DON stated that behavior monitoring is documented in progress notes. When informed of POC behavior monitoring listing physical and verbal behaviors directed at others and progress notes do not reflect monitoring of behaviors that identifies resident's individualized behavior or expression of depression and resident's statements about how she expresses depression and staff perceptions are different and is not being monitored or tracked. DON nodded head and stated "I understand what you are saying." DON stated that facility had not identified R10's specific behaviors or monitored these behaviors.
, Resident 6
1. Review of R6's Facesheet indicated R6 was admitted on 09/15/23, with diagnoses including major depressive disorder (mood disorder that causes a persistent feeling of sadness) and anxiety (a feeling of fear, dread, and uneasiness).
During an interview on 04/23/24, at 03:26 PM, Licensed Practical Nurse (LPN) 1 stated, R6 will become "agitated of certain staff" and will start "yelling and cussing and sudden outburst and being angry." LPN 1 further explained R6 manifestation of depression when "he is not eating or taking snack. He's depress if he's not talking to his favorite staff."
Review of R6's Order Summary Report indicated an order for the following anti-depressant medications with a start date of 12/04/23:
Venlafaxine HCl ER Oral Tablet Extended Release 24 Hour 75 MG to 225 mg by mouth one time a day related to Major Depressive Disorder and Anxiety Disorder and
Wellbutrin SR Oral Tablet Extended Release 12 Hour 150 MG (Bupropion HCl) to give 1 tablet by mouth every morning and at bedtime related to related to Major Depressive Disorder and Anxiety Disorder.
Review of R6's Medication Administration Record (MAR) for April 2024 indicated, "Monitor for effectiveness of psychotropic medication administration. Progress note behaviors Qshift [every shift] every day and night shift" with a start date of "02/16/2024 [at] 2200 [10 PM]."
Review of R6's care plan for the use of Psychotropics (medications that affect behavior, mood, thoughts, or perception) initiated on 12/05/23 indicated, "PSYCHOTROPIC: [R6] is on antidepressant medication Venlafaxine HCl and Wellbutrin SR r/t [related to] DX [diagnosis] for major depressive disorder" With the following Interventions: "Document in POC (Point of Care) and or PN (progress notes), identified behaviors and interventions as they occur. Give psychotropic meds per order. Gradual dose reductions as recommended. Notify responsible party and PCP (Primary Care Physicia) with any changes or recommendations. Monitor for effectiveness and monitor for adverse side effects including however not limited to: drowsiness, headache, lightheadedness, nausea, vomiting, constipation, rash, itchiness, SOB (shortness of breath), chewing movements, puckering of the mouth, loss of coordination, muscle tremors, jerking movements and stiffness, rocking movements, dry mouth, and runny nose. Report to MD adverse side effects. PHQ-9 [questionaire for depressive symptoms] as needed. Refer to psychiatrist/counselor as needed. Will be monitored at Psychotropic meeting quarterly and PRN (pro re nata, as needed)."
During an interview on 04/23/24, at 04:30 PM, R6's order summary, MAR and care plan were reviewed with the Director of Nursing (DON). The DON acknowledged that specific target behaviors for the use of antidepressants were not identified, monitored and evaluated. The DON further stated,
"It has to be specific (referring to resident's behavior). The staff should monitor specific behavior or specific manifestation."